CN102994409B - New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof - Google Patents

New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof Download PDF

Info

Publication number
CN102994409B
CN102994409B CN201210260349.XA CN201210260349A CN102994409B CN 102994409 B CN102994409 B CN 102994409B CN 201210260349 A CN201210260349 A CN 201210260349A CN 102994409 B CN102994409 B CN 102994409B
Authority
CN
China
Prior art keywords
penneri
ubiquinone
application
bacterial strain
coenzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210260349.XA
Other languages
Chinese (zh)
Other versions
CN102994409A (en
Inventor
钟卫鸿
孔卓怡
柳华贵
钟莉
邱乐泉
吴石金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Zhongke Long Life Medical Science And Technology Co Ltd
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN201210260349.XA priority Critical patent/CN102994409B/en
Publication of CN102994409A publication Critical patent/CN102994409A/en
Application granted granted Critical
Publication of CN102994409B publication Critical patent/CN102994409B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides a new bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications of the proteus penneri CA8 in preparation of the coenzyme Q10 by microbial fermentation. The bacterial strain is preserved in China Center for Type Culture Collection, the address is 430072, Wuhan University, Wuhan, China, the preservation number is CCTCC No: M2012208, and the preservation date is June 10, 2012. The new bacterial strain-proteus penneri CA8 for generating the coenzyme Q10 has the following main beneficial effects: the new coenzyme Q10 producing strain is provided, and the coenzyme Q10 is prepared by utilizing the microbial fermentation of the strain, so that yield is high, the subsequent extraction method is simple, and the industrial production is facilitated.

Description

Produce ubiquinone 10new bacterial strain P.penneri CA8 and application thereof
(1) technical field
The present invention relates to a strain and produce ubiquinone 10new bacterial strain---P.penneri CA8 and prepare ubiquinone in microorganism fermentation 10in application, belong to microbiological pharmacy field.
(2) background technology
Ubiquinone 10(CoenzymeQ 10, CoQ 10) be extensively present in animal, plant and microbe, be hydrogen carrier important in biomass cells respiratory chain, be also a kind of good biochemical drug.It has oxidation-resistance, eliminates free radical, improves the functions such as immunity of organisms, has been widely used in the treatment of the diseases such as all kinds of heart troubles, diabetes, cancer, acute, chronic hepatitis, parkinsonism.Prepare ubiquinone 10method mainly contain zooblast extraction method, tobacco leaf Salanesol semi-synthesis method, synthesis method, microbe fermentation method or culture plant cell method completely.Compare with additive method, microbe fermentation method has that its lytic activity is high, raw materials cost is low, easy to control and can realize the features such as scale operation.Obtaining good fermentation strain is Production by Microorganism Fermentation ubiquinone 10one of key.The ubiquinone of having reported at present 10fermentation strain mainly belongs to Pseudomonas, Saccharomycodes, photosynthetic bacterium genus and paracoccus etc.Fermentation thalline extracts ubiquinone 10method mostly is alcohol alkali soap method for post extraction, and step is loaded down with trivial details, waste time and energy, and it is larger to extract solvent loss.
(3) summary of the invention
The object of the invention is in order to provide a strain to produce ubiquinone 10output is new bacterial strain preferably, and utilizes this strain fermentating liquid to prepare ubiquinone 10method.
The technical solution used in the present invention is:
One strain ubiquinone 10bacterium---P.penneri (Proteus penneri) CA8, is preserved in Chinese Typical Representative culture collection center, address: China in generation, Wuhan, Wuhan University, 430072, deposit number: CCTCC No:M 2012208, preservation date: on June 10th, 2012.
Described P.penneri CA8 feature is as follows: bacterial strain on LB agar plate, cultivate after 1 day, be translucent moist, less, circle, smooth surface, easily provokes; It is shaft-like that thalline is, and size is (0.4~1.0) μ m * (0.8~1.8) μ m, and tool whole body flagellum, can move, and Gram-negative, without gemma; Amphimicrobian, phenylalanine test is positive, and oxydase reaction, gelatin hydrolysis test, indole test, IMViC test, V-P reaction are negative, and utilize glucose, lactose etc. to produce acid, and unfavorable with saligenin, optimum growth temperature is 37 ℃.
CA8 bacterial strain of the present invention, separated from the Ebolowa of Cameroon soil, through the Phylogenetic Analysis of morphology, Physiology and biochemistry, Biolog GEN Ш evaluation and 16S rRNA sequence, find that this bacterial strain belongs to P.penneri, called after Proteus penneri CA8.There is not yet at present relevant Bacillus proteus is both at home and abroad applied at ubiquinone 10the research report of producing.
The present invention ferment thalline ultrasonication and extract ubiquinone 10technique have no equally report.
The invention still further relates to described P.penneri CA8 and prepare ubiquinone in microorganism fermentation 10in application.
Described being applied as: with P.penneri CA8, be inoculated in the liquid nutrient medium that is applicable to P.penneri, at 30 ~ 37 ℃, cultivate 48 ~ 60 h, the centrifugal collection wet thallus of gained fermented liquid, wet thallus extracts and obtains described ubiquinone through fragmentation 10.
The described liquid nutrient medium that is applicable to P.penneri is the conventional liquid nutrient medium that is applicable to P.penneri, can prepare by following composition: carbon source 10 ~ 20 g, nitrogenous source 5 ~ 15 g, KH in the present invention 2pO 40.5 g, Na 2hPO 41.5 g, MgSO 40.5 g, water 1000 ml, pH6.0 ~ 8.0.
Described carbon source is the conventional carbon source for substratum preparation, as glucose, sucrose, maltose, lactose etc., is preferably lactose.
Described nitrogenous source is the conventional carbon source for substratum preparation, as yeast extract paste, ammonium sulfate etc., is preferably yeast extract paste.
More preferred, described in be applicable to P.penneri liquid nutrient medium by following composition, prepare: add lactose 40 g, yeast extract paste 40 g, KH 2pO 40.5 g, Na 2hPO 41.5 g, MgSO 40.5 g, water 1000 ml, pH8.0.
Preferably, described fragmentation is extracted as ultrasonication and extracts, and method is as follows: wet thallus is moved in centrifuge tube, add enough ethanol, mix, and after 300 ~ 500 W supersound process 8 ~ 10 min, centrifugal, filter, in filtrate, obtain described ubiquinone 10.
Beneficial effect of the present invention is mainly reflected in: provide a strain new ubiquinone 10produce bacterium, utilize this strain microorganism fermentation to prepare ubiquinone 10, output is high, and subsequent extracted method is simple, is beneficial to suitability for industrialized production.
(4) accompanying drawing explanation
Fig. 1 is the Electronic Speculum figure (* 30000) of P.penneri (Proteus penneri) CA8;
Fig. 2 is that different carbon sources are to CA8 ubiquinone 10the impact of output;
Fig. 3 is that different nitrogen sources is to CA8 ubiquinone 10the impact of output;
Fig. 4 is that lactose concn is to CA8 ubiquinone 10the impact of output;
Fig. 5 is that yeast extract paste concentration is to CA8 ubiquinone 10the impact of output;
Fig. 6 is that temperature is to ubiquinone 10the impact of output;
Fig. 7 is that liquid amount is to ubiquinone 10the impact of output;
Fig. 8 is that initial pH value is to ubiquinone 10the impact of output.
(5) embodiment
Below in conjunction with specific embodiment, the present invention is described further, but protection scope of the present invention is not limited in this:
Embodiment: ubiquinone is produced in the separation of P.penneri (Proteus penneri) CA8, evaluation and fermentation thereof 10characteristic
1, the separation of bacterial strain:
(1) collected specimens
Gather after the Ebolowa of Cameroon pedotheque, get 10 g, add sterilized water 90 ml, make Soil Slurry.Draw supernatant liquor and make 10 with sterilized water dilution -1, 10 -2, 10 -3, 10 -4, 10 -5, 10 -6different extent of dilution.
(2) strains separation
Get bacteria suspension 1 ml, in the flat lining out of selectivity, selective medium was prepared by following composition: isoprene 0.5 ml, (NH 4) 2sO 41.0 g, KH 2pO 44.5 g, Na 2hPO 412H 2o 21.6 g, agar 15~20 g, water 1000 ml, pH 7.0.
According to the ordinary method of microorganism Pure strain separation, above-mentioned separation and Culture is placed to 2~3 d based on 28 ℃.A plurality of single bacterium colonies of picking, are inoculated on slant medium, and numbering is preserved.In liquid medium within, carry out fermentable check, result obtains a strain ubiquinone again 10the bacterial strain CA8 that output is higher.Substratum used was prepared by following composition: glucose 20 g, peptone 10 g, yeast extract paste 10 g, KH 2pO 40.5 g, Na 2hPO 41.5 g, MgSO 47H 2o 0.5 g, water 1000 ml, pH7.0.(as being solid medium, adding again the agar of 20 g/L).
2, the evaluation of bacterial strain
(1) ubiquinone 10produce thalline and the colony morphology characteristic of bacterium CA8
Ubiquinone 10it is shaft-like producing bacterium CA8, and size is (0.4~1.0) μ m * (0.8~1.8) μ m, Gram-negative, and without gemma, tool whole body flagellum, can move; Bacterium colony is translucent moist, less, circle, and smooth surface, easily provokes.
(2) ubiquinone 10produce the physiological and biochemical property of bacterium CA8
Physiological and biochemical property is: amphimicrobian, and phenylalanine test is positive, and oxydase reaction, gelatin hydrolysis test, indole test, IMViC test, V-P reaction are negative, and utilize glucose, lactose etc. to produce acid, the unfavorable saligenin of using.
The Physiological-biochemical Characters of the P.penneri that above-mentioned mycology feature and document (uncle Jie Shi Bacteria Identification handbook) are edited and recorded matches.In conjunction with 16S rRNA sequence homology analysis and the Biolog systems analysis result of bacterial strain, this bacterium pearl is accredited as the product ubiquinone that belongs to P.penneri 10new bacterium pearl.
3, produce ubiquinone 10performance
P.penneri (Proteus penneri) CA8, with 5 % inoculum sizes, is inoculated in to 500 ml 100 ml liquid nutrient mediums (20 g carbon sources, 10 g peptones, 10 g yeast extract pastes, KH are housed 2pO 40.5 g, Na 2hPO 41.5 g, MgSO 40.5 g, water complements to 1000 ml, pH 7.0) shaking flask in, using these several conventional carbon sources of glucose, sucrose, maltose and lactose as the carbon source of fermentation, investigate its cell growth total amount and ubiquinone 10the impact of total amount, carries out single factor research of carbon source.
Result as shown in Figure 2, shows that the utilization of carbon source is to bacteria growing amount and ubiquinone 10yield effect is more inhomogeneous.From bacteria growing amount and ubiquinone 10proportionlity between output, lactose is optimum carbon source.
Carry out on this basis the impact research of lactose concn interpolation, result as shown in Figure 4, ubiquinone when Inclusion of Lactose is 40 g/L 10output is higher.
P.penneri (Proteus penneri) CA8, with 5 % inoculum sizes, is inoculated in to liquid nutrient medium (40 g lactose, 10 g nitrogenous sources, KH 2pO 40.5 g, Na 2hPO 41.5 g, MgSO 40.5 g, water complements to 1000 ml, pH 7.0), as shown in Figure 3, result shows the result of nitrogenous source: in organic nitrogen source, take yeast extract paste as best, itself and inorganic nitrogen-sourced ammonium sulfate comparison, the inorganic nitrogen-sourced thalli growth that is unfavorable for.Carry out on this basis the impact research of yeast extract paste concentration interpolation, as shown in Figure 5, result shows result: ubiquinone when yeast extract paste addition is 40 g/L 10output is higher.
Investigate respectively differing temps, liquid amount, initial pH value cell growth total amount and ubiquinone 10the impact of total amount.Result, as shown in Fig. 6, Fig. 7, Fig. 8, shows when temperature, liquid amount, initial pH are divided into 30 ℃, 80 ml, fermentation preparation of cozymase Q 8.0 time 10best.
With this understanding, by bacterial strain P.penneri (Proteus penneri) CA8 fermentation, produce ubiquinone 10output the highest, reached 105.1 mg/L, than before optimizing, improved 500%.

Claims (8)

1. a strain ubiquinone 10bacterium---P.penneri (Proteus penneri) CA8, is preserved in Chinese Typical Representative culture collection center, address: China in generation, Wuhan, Wuhan University, 430072, deposit number: CCTCC No:M2012208, preservation date: on June 10th, 2012.
2. P.penneri CA8 as claimed in claim 1 prepares ubiquinone in microorganism fermentation 10in application.
3. application as claimed in claim 2, described in it is characterized in that, be applied as: with P.penneri CA8, be inoculated in the liquid nutrient medium that is applicable to P.penneri, at 30~37 ℃, cultivate 48~60h, the centrifugal collection wet thallus of gained fermented liquid, wet thallus extracts and obtains described ubiquinone through fragmentation 10.
4. application as claimed in claim 3, the liquid nutrient medium that is applicable to P.penneri described in it is characterized in that is prepared by following composition: carbon source 10~20g, nitrogenous source 5~15g, KH 2pO 40.5g, Na 2hPO 41.5g, MgSO 40.5g, water 1000ml, pH6.0~8.0.
5. application as claimed in claim 4, is characterized in that described carbon source is lactose.
6. application as claimed in claim 4, is characterized in that described nitrogenous source is yeast extract paste.
7. application as claimed in claim 3, the liquid nutrient medium that is applicable to P.penneri described in it is characterized in that is prepared by following composition: add lactose 40g, yeast extract paste 40g, KH 2pO 40.5g, Na 2hPO 41.5g, MgSO 40.5g, water 1000ml, pH8.0.
8. application as claimed in claim 3, is characterized in that described fragmentation is extracted as ultrasonication and extracts, and method is as follows: wet thallus is moved in centrifuge tube, add enough ethanol, mix, after 300~500W supersound process, 8~10min, centrifugal, filter, in filtrate, obtain described ubiquinone 10.
CN201210260349.XA 2012-07-20 2012-07-20 New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof Active CN102994409B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210260349.XA CN102994409B (en) 2012-07-20 2012-07-20 New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210260349.XA CN102994409B (en) 2012-07-20 2012-07-20 New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof

Publications (2)

Publication Number Publication Date
CN102994409A CN102994409A (en) 2013-03-27
CN102994409B true CN102994409B (en) 2014-09-03

Family

ID=47923522

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210260349.XA Active CN102994409B (en) 2012-07-20 2012-07-20 New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof

Country Status (1)

Country Link
CN (1) CN102994409B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066080A (en) * 1961-03-22 1962-11-27 Merck & Co Inc Fermentation production of coenzyme q-10
US3658648A (en) * 1966-09-17 1972-04-25 Takeda Chemical Industries Ltd Method for the production of coenzyme q
CN101654664A (en) * 2009-09-25 2010-02-24 厦门百拓生物工程有限公司 Fermentation production method and application of high-yield exopolysaccharide strain and amylase thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066080A (en) * 1961-03-22 1962-11-27 Merck & Co Inc Fermentation production of coenzyme q-10
US3658648A (en) * 1966-09-17 1972-04-25 Takeda Chemical Industries Ltd Method for the production of coenzyme q
CN101654664A (en) * 2009-09-25 2010-02-24 厦门百拓生物工程有限公司 Fermentation production method and application of high-yield exopolysaccharide strain and amylase thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Coenzyme Q. XVII. Isolation of Coenzyme Q10 from Bacterial Fermentation;A.C.PAGE,JR.等;《ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS》;19601231;第89卷;全文 *

Also Published As

Publication number Publication date
CN102994409A (en) 2013-03-27

Similar Documents

Publication Publication Date Title
CN102888351B (en) Prodigiosin high-producing strain and production method thereof
CN106554931B (en) Carboxylic acid bacterium bailii and application thereof
CN104342390A (en) Sinorhizobium meliloti strain and composition and application of sinorhizobium meliloti strain
CN102337312A (en) Method for increasing yield of chondroitin sulfate produced by fermentation method
CN102586151B (en) High-yield polysaccharide strain and method for producing polysaccharide by utilizing strain through fermentation
Ramprakash et al. Biohydrogen production from rice mill wastewater using mutated Enterobacter aerogenes
CN105017086A (en) Separation and purification method for L-citrulline
CN103571772A (en) Novel strain for producing butanol and method for producing butanol
CN103421714A (en) Bacillus shackletonii and application thereof in fermentation production of polyhydroxybutyrate
CN104630166A (en) Method for producing low-temperature glucose oxidase by virtue of microbial fermentation
CN103276019A (en) Method for promoting lycopene synthesis in blakeslea trispora
CN104673712A (en) Bacterial strain for producing alcohol fuels by synchronously utilizing glucose and xylose and application of bacterial strain
CN104630167A (en) Method for producing low-temperature glucose oxidase by fermentation of marine microorganisms
CN102676406B (en) Candida tropicalis used for fermenting and producing ribonucleic acid and application thereof
CN105176859A (en) Strain MQO-153 for production of arginine deiminase
CN106995789B (en) Resveratrol zymocyte and application thereof
CN107937307A (en) One plant of bacteria cellulose Producing Strain and its optimal fermentation condition
CN116200286B (en) Clostridium thermocellum capable of efficiently saccharifying cellulose and application thereof
CN108384730B (en) Lactobacillus paracasei and application thereof in conversion synthesis of phenyllactic acid
CN103468606B (en) Klebsiella oxytoca and application thereof in allitol production
CN114015607B (en) Bacillus amyloliquefaciens for high yield of 5-methyltetrahydrofolic acid and application thereof
CN103146595A (en) Bacillus subtilis and method for fermentation production of D- ribose
CN102994409B (en) New bacterial strain-proteus penneri CA8 for generating coenzyme Q10 and applications thereof
CN105177075A (en) Method for preparation of L-citrulline with arginine as raw material
CN101177670B (en) Novel strain sphingosine gingivalis ZUTE03 for producing coenzyme Q10 and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20181031

Address after: 322000 No. 269 embroidery Road West, Beiyuan street, Yiwu, Jinhua, Zhejiang.

Patentee after: Zhejiang Zhongke long life medical science and Technology Co Ltd

Address before: 310014 Chao Wang Road, Xiacheng City, Hangzhou, Zhejiang Province, No. 18

Patentee before: Zhejiang University of Technology